Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2025)

Arcutis Biotherapeutics has reported Asset Utilization Ratio over the past 4 years, most recently at 0.92 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.92 for Q4 2025, up 86.04% from a year ago — trailing twelve months through Dec 2025 was 0.92 (up 86.04% YoY), and the annual figure for FY2025 was 0.95, up 97.23%.
  • Asset Utilization Ratio for Q4 2025 was 0.92 at Arcutis Biotherapeutics, up from 0.87 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ARQT hit a ceiling of 0.92 in Q4 2025 and a floor of 0.0 in Q3 2022.
  • Median Asset Utilization Ratio over the past 4 years was 0.25 (2024), compared with a mean of 0.34.
  • Biggest five-year swings in Asset Utilization Ratio: soared 7346.58% in 2023 and later soared 86.04% in 2025.
  • Arcutis Biotherapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then skyrocketed by 2010.41% to 0.16 in 2023, then skyrocketed by 204.78% to 0.49 in 2024, then soared by 86.04% to 0.92 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.92 (Q4 2025), 0.87 (Q3 2025), and 0.75 (Q2 2025) per Business Quant data.